Coronary Microcirculation
Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
GS
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Gilead SciencesRnalozine
Clinical Trials (1)
Total enrollment: 7 patients across 1 trials
Impact of Ranolazine on Coronary Microcirculatory Resistance
Start: May 2012Est. completion: Mar 20167 patients
N/ACompleted
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Territory Sales Manager - Iowa / Nebraska
HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
21h ago
From $150K/yr
Clinical Consultant
Johnson & Johnson
North Ryde, New South Wales, Australia
22h ago
Regional Sales Specialist (Orange County / Long Beach, CA) - Johnson & Johnson MedTech, Electrophysiology
Johnson & Johnson
Irvine, California, United States of America
22h ago
$100K - $135K/yr
Trainee Technical Specialist
Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
22h ago
Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90
Johnson & Johnson
Issy-les-Moulineaux, France
22h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space